Platelet glycoprotein IIb as a target antigen in two patients with chronic idiopathic thrombocytopenic purpura. 1987

Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
Second Department of Internal Medicine, Osaka University Medical School, Japan.

We have investigated the target antigens recognized by anti-platelet antibodies in patients with chronic idiopathic thrombocytopenic purpura (ITP) using an immunoblot procedure which could electrically separate the glycoprotein (GP) IIb/IIIa complex into GPIIb and GPIIIa. Various platelet proteins, having molecular weights of 167, 160, 145, 135, 124, 102, 92 and 80 kD, were recognized by circulating antibodies in 11 of 40 ITP patients. We identified the 145 kD antigen band, seen in two ITP patients, as GPIIb using thrombasthenic platelets as a source of target antigens. In one patient the anti-GPIIb antibody reacted with autologous GPIIb. These studies provide direct evidence for the presence of autoantibodies against GPIIb in some ITP patients.

UI MeSH Term Description Entries
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
December 1995, British journal of haematology,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
November 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
April 1984, British journal of haematology,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
December 1978, Journal of clinical pathology,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
June 1984, Annals of internal medicine,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
July 1984, Blood,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
January 1993, Acta haematologica,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
February 1986, Blood,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
February 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Tomiyama, and Y Kurata, and H Mizutani, and Y Kanakura, and T Tsubakio, and T Yonezawa, and S Tarui
September 1985, The Keio journal of medicine,
Copied contents to your clipboard!